Anticancer therapy within the last 30 days of life: Results of an audit and re-audit cycle from a regional cancer center.
Nguyen Mike, Alysson Wann, Babak Tamjid, Arvind Sahu, Javier Torres
Journal of Clinical Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2019
e18260 Background: The therapeutic landscape in medical oncology continues to expand significantly. Newer therapies, especially immunotherapy, offer the hope of profound and durable responses with more tolerable side effect profiles. Integrating this information into the decision making process is challenging for patients and oncologists. Systemic anticancer treatment within the last thirty days of life is a key quality of care indicator and is one parameter used in the assessment of aggressiveness of care. Methods: A retrospective review of medical records of all patients previously treated at Goulburn Valley Health oncology department who died between 1 January 2015 and 30 June 2018 was c..View full abstract